Kendall Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.58M Buy
55,752
+8,210
+17% +$380K 0.68% 41
2025
Q1
$2.9M Sell
47,542
-90
-0.2% -$5.49K 0.85% 34
2024
Q4
$2.69M Buy
47,632
+2,985
+7% +$169K 0.79% 38
2024
Q3
$2.31M Sell
44,647
-2,295
-5% -$119K 0.71% 42
2024
Q2
$1.95M Sell
46,942
-1,542
-3% -$64K 0.65% 46
2024
Q1
$2.63M Buy
48,484
+1,743
+4% +$94.5K 0.9% 26
2023
Q4
$2.4M Buy
46,741
+610
+1% +$31.3K 0.93% 26
2023
Q3
$2.68M Buy
46,131
+1,022
+2% +$59.3K 1.19% 17
2023
Q2
$2.89M Buy
45,109
+275
+0.6% +$17.6K 1.26% 14
2023
Q1
$3.11M Buy
44,834
+1,066
+2% +$73.9K 1.49% 14
2022
Q4
$3.15M Sell
43,768
-1,771
-4% -$127K 1.59% 12
2022
Q3
$3.24M Buy
45,539
+1,240
+3% +$88.1K 1.88% 9
2022
Q2
$3.41M Sell
44,299
-430
-1% -$33.1K 1.88% 10
2022
Q1
$3.27M Buy
44,729
+2,315
+5% +$169K 1.58% 14
2021
Q4
$2.65M Buy
42,414
+3,472
+9% +$217K 1.26% 20
2021
Q3
$2.3M Buy
38,942
+5,895
+18% +$349K 1.25% 22
2021
Q2
$2.21M Buy
33,047
+2,780
+9% +$186K 1.24% 21
2021
Q1
$1.91M Buy
30,267
+4,335
+17% +$274K 1.18% 25
2020
Q4
$1.61M Buy
25,932
+2,320
+10% +$144K 1.17% 30
2020
Q3
$1.42M Buy
23,612
+930
+4% +$56.1K 1.24% 27
2020
Q2
$1.33M Buy
22,682
+5,782
+34% +$340K 1.28% 29
2020
Q1
$942K Sell
16,900
-3,125
-16% -$174K 1.07% 33
2019
Q4
$1.29M Buy
20,025
+2,170
+12% +$139K 1.01% 39
2019
Q3
$905K Buy
17,855
+2,605
+17% +$132K 0.8% 48
2019
Q2
$692K Buy
15,250
+2,285
+18% +$104K 0.63% 60
2019
Q1
$619K Buy
12,965
+4,630
+56% +$221K 0.59% 60
2018
Q4
$433K Buy
8,335
+2,535
+44% +$132K 0.45% 70
2018
Q3
$360K Buy
+5,800
New +$360K 0.31% 83